8-K/A XBRL

FORM 8-K/A

Company: DiaMedica Therapeutics Inc.
Filed: March 10, 2023
Period of Report: March 1, 2023
Accession Number: 0001437749-23-006083

View Document ↗ View on SEC.gov ↗